Corporate

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Corporate

MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin

Corporate - Investors

6 April 2020

The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association

Corporate

10 September 2019

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.